Literature DB >> 32536216

Inverse time trends of peptic ulcer and reflux esophagitis show significant association with reduced prevalence of Helicobacter pylori infection.

Nobutake Yamamichi1, Yutaka Yamaji1,2, Takeshi Shimamoto2, Yu Takahashi1, Kenichiro Majima3, Ryoichi Wada2, Tohru Mitsushima2, Kazuhiko Koike1.   

Abstract

INTRODUCTION: Recent prevalence and trends of gastric/duodenal ulcer (GU/DU) and reflux esophagitis (RE) are inadequate.
METHODS: We reviewed the records of consecutive 211,347 general population subjects from 1991 to 2015.
RESULTS: During the 25 years, the prevalence of GU and DU has gradually decreased (from 3.0% to 0.3% and from 2.0% to 0.3%) whereas that of RE has markedly increased (from 2.0% to 22%). The prevalence of Helicobacter pylori (HP) infection has decreased from 49.8% (in 1996) to 31.2% (in 2010). Multivariable logistic regression analyses demonstrated that HP infection was positively associated with GU/DU and negatively associated with RE with statistical significance. The panel data analyses showed that reduced rate of HP infection is proportionally correlated with decrease of GU/DU and inversely correlated with increase of RE. It is further suggested other latent factors should be important for changed prevalence of these three acid-related diseases. Age-period-cohort analysis indicated the significant association of older age, male gender, and absence of HP infection with RE.
CONCLUSIONS: The prevalence of GU and DU has gradually decreased whereas that of RE has markedly increased in Japan. Inverse time trends of peptic ulcer and reflux esophagitis are significantly associated with reduced prevalence of HP infection. KEY MESSAGES The prevalence of gastric and duodenal ulcer has gradually decreased whereas that of reflux esophagitis has markedly increased in Japan. The prevalence of Helicobacter pylori infection in Japan has greatly decreased from 49.8% to 31.2% during the 14 years (from 1996 to 2010). Inverse time trends of peptic ulcer and reflux esophagitis are associated with reduced prevalence of Helicobacter pylori infection with statistical significance.

Entities:  

Keywords:  Helicobacter pylori ; age-period-cohort analysis; duodenal ulcer; gastric ulcer; panel data analysis; peptic ulcer; reflux esophagitis

Year:  2020        PMID: 32536216      PMCID: PMC7877954          DOI: 10.1080/07853890.2020.1782461

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  28 in total

1.  Age-period-cohort models for the Lexis diagram.

Authors:  B Carstensen
Journal:  Stat Med       Date:  2007-07-10       Impact factor: 2.373

Review 2.  Gastro-oesophageal reflux disease.

Authors:  Paul Moayyedi; Nicholas J Talley
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

3.  Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Masao Ichinose; Yu Takahashi; Chihiro Minatsuki; Rie Matsuda; Chiemi Nakayama; Takeshi Shimamoto; Shinya Kodashima; Satoshi Ono; Yosuke Tsuji; Keiko Niimi; Yoshiki Sakaguchi; Yosuke Kataoka; Itaru Saito; Itsuko Asada-Hirayama; Chihiro Takeuchi; Seiichi Yakabi; Hikaru Kaikimoto; Yuta Matsumoto; Daisuke Yamaguchi; Natsuko Kageyama-Yahara; Mitsuhiro Fujishiro; Ryoichi Wada; Toru Mitsushima; Kazuhiko Koike
Journal:  Gastric Cancer       Date:  2015-10-20       Impact factor: 7.370

Review 4.  Helicobacter pylori and Nonmalignant Diseases.

Authors:  Georgios S Potamitis; Anthony T R Axon
Journal:  Helicobacter       Date:  2015-09       Impact factor: 5.753

5.  Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.

Authors:  Y Yamaji; T Mitsushima; H Ikuma; M Okamoto; H Yoshida; T Kawabe; Y Shiratori; K Saito; K Yokouchi; M Omata
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

6.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

Review 7.  Peptic ulcer disease.

Authors:  Peter Malfertheiner; Francis K L Chan; Kenneth E L McColl
Journal:  Lancet       Date:  2009-08-13       Impact factor: 79.321

Review 8.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

Review 9.  Screening for gastric cancer in Asia: current evidence and practice.

Authors:  Wai K Leung; Ming-shiang Wu; Yasuo Kakugawa; Jae J Kim; Khay-guan Yeoh; Khean Lee Goh; Kai-chun Wu; Deng-chyang Wu; Jose Sollano; Udom Kachintorn; Takuji Gotoda; Jaw-town Lin; Wei-cheng You; Enders K W Ng; Joseph J Y Sung
Journal:  Lancet Oncol       Date:  2008-03       Impact factor: 41.316

10.  Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.

Authors:  Chihiro Minatsuki; Nobutake Yamamichi; Takeshi Shimamoto; Hikaru Kakimoto; Yu Takahashi; Mitsuhiro Fujishiro; Yoshiki Sakaguchi; Chiemi Nakayama; Maki Konno-Shimizu; Rie Matsuda; Satoshi Mochizuki; Itsuko Asada-Hirayama; Yosuke Tsuji; Shinya Kodashima; Satoshi Ono; Keiko Niimi; Toru Mitsushima; Kazuhiko Koike
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more
  2 in total

1.  Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan.

Authors:  Nobutake Yamamichi; Takeshi Shimamoto; Yu Takahashi; Mami Takahashi; Chihiro Takeuchi; Ryoichi Wada; Mitsuhiro Fujishiro
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

2.  Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.

Authors:  Akiko Kowada; Masahiro Asaka
Journal:  Helicobacter       Date:  2022-03-27       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.